These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36701008)

  • 21. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
    Jellinger KA
    Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progressive supranuclear palsy.
    Giagkou N; Höglinger GU; Stamelou M
    Int Rev Neurobiol; 2019; 149():49-86. PubMed ID: 31779824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism.
    Assogna F; Pellicano C; Cravello L; Savini C; Macchiusi L; Pierantozzi M; Stefani A; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G
    Brain Behav; 2019 Dec; 9(12):e01448. PubMed ID: 31743601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Track density imaging: A reliable method to assess white matter changes in Progressive Supranuclear Palsy with predominant parkinsonism.
    Nigro S; Barbagallo G; Bianco MG; Morelli M; Arabia G; Quattrone A; Gasparini S; Cascini GL; Quattrone A
    Parkinsonism Relat Disord; 2019 Dec; 69():23-29. PubMed ID: 31665684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy.
    Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Steiger R; Wildauer M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    Parkinsonism Relat Disord; 2018 Apr; 49():81-87. PubMed ID: 29463454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropsychological assessment could distinguish among different clinical phenotypes of progressive supranuclear palsy: A Machine Learning approach.
    Vaccaro MG; Sarica A; Quattrone A; Chiriaco C; Salsone M; Morelli M; Quattrone A
    J Neuropsychol; 2021 Sep; 15(3):301-318. PubMed ID: 33231380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in aphasia syndromes between progressive supranuclear palsy-Richardson's syndrome, behavioral variant frontotemporal dementia and Alzheimer's dementia.
    Ransmayr L; Fuchs A; Ransmayr-Tepser S; Kommenda R; Kögl M; Schwingenschuh P; Fellner F; Guger M; Eggers C; Darkow R; Mangesius S; Ransmayr G
    J Neural Transm (Vienna); 2022 Aug; 129(8):1039-1048. PubMed ID: 35821453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diffusion tractography of superior cerebellar peduncle and dentatorubrothalamic tracts in two autopsy confirmed progressive supranuclear palsy variants: Richardson syndrome and the speech-language variant.
    Gatto RG; Martin PR; Ali F; Clark HM; Duffy JR; Utianski RL; Botha H; Machulda MM; Dickson DW; Josephs KA; Whitwell JL
    Neuroimage Clin; 2022; 35():103030. PubMed ID: 35597031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy.
    Ali F; Martin PR; Botha H; Ahlskog JE; Bower JH; Masumoto JY; Maraganore D; Hassan A; Eggers S; Boeve BF; Knopman DS; Drubach D; Petersen RC; Dunkley ED; van Gerpen J; Uitti R; Whitwell JL; Dickson DW; Josephs KA
    Mov Disord; 2019 Aug; 34(8):1144-1153. PubMed ID: 30726566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicenter Validation of Metabolic Abnormalities Related to PSP According to the MDS-PSP Criteria.
    Martí-Andrés G; van Bommel L; Meles SK; Riverol M; Valentí R; Kogan RV; Renken RJ; Gurvits V; van Laar T; Pagani M; Prieto E; Luquin MR; Leenders KL; Arbizu J
    Mov Disord; 2020 Nov; 35(11):2009-2018. PubMed ID: 32822512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Unusual Presentation of Progressive Supranuclear Palsy.
    Dec-Cwiek M; Boczarska-Jedynak M; Pera J
    Neurol India; 2021; 69(6):1789-1793. PubMed ID: 34979690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progression of two Progressive Supranuclear Palsy phenotypes with comparable initial disability.
    Shoeibi A; Litvan I; Tolosa E; Ser TD; Lee E;
    Parkinsonism Relat Disord; 2019 Sep; 66():87-93. PubMed ID: 31307919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy.
    Sakae N; Josephs KA; Litvan I; Murray ME; Duara R; Uitti RJ; Wszolek ZK; Graff-Radford NR; Dickson DW
    Mov Disord; 2019 Nov; 34(11):1655-1662. PubMed ID: 31433871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy.
    Pilotto A; Gazzina S; Benussi A; Manes M; Dell'Era V; Cristillo V; Cosseddu M; Turrone R; Alberici A; Padovani A; Borroni B
    Neurodegener Dis; 2017; 17(6):286-291. PubMed ID: 28881351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes?
    Shoeibi A; Litvan I; Juncos JL; Bordelon Y; Riley D; Standaert D; Reich SG; Shprecher D; Hall D; Marras C; Kluger B; Olfati N; Jankovic J
    Parkinsonism Relat Disord; 2019 Dec; 69():34-39. PubMed ID: 31665686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
    Fiorenzato E; Antonini A; Camparini V; Weis L; Semenza C; Biundo R
    J Neural Transm (Vienna); 2019 Nov; 126(11):1437-1445. PubMed ID: 31432258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy.
    Picillo M; Cuoco S; Carotenuto I; Abate F; Erro R; Volpe G; Pellecchia MT; Catricalà E; Cappa S; Barone P
    PLoS One; 2019; 14(10):e0223621. PubMed ID: 31603934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progressive Supranuclear Palsy: an Update.
    Armstrong MJ
    Curr Neurol Neurosci Rep; 2018 Feb; 18(3):12. PubMed ID: 29455271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.
    Jabbari E; Holland N; Chelban V; Jones PS; Lamb R; Rawlinson C; Guo T; Costantini AA; Tan MMX; Heslegrave AJ; Roncaroli F; Klein JC; Ansorge O; Allinson KSJ; Jaunmuktane Z; Holton JL; Revesz T; Warner TT; Lees AJ; Zetterberg H; Russell LL; Bocchetta M; Rohrer JD; Williams NM; Grosset DG; Burn DJ; Pavese N; Gerhard A; Kobylecki C; Leigh PN; Church A; Hu MTM; Woodside J; Houlden H; Rowe JB; Morris HR
    JAMA Neurol; 2020 Mar; 77(3):377-387. PubMed ID: 31860007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging counterpart of postural instability and vertical ocular dysfunction in patients with PSP: A multimodal MRI study.
    Quattrone A; Caligiuri ME; Morelli M; Nigro S; Vescio B; Arabia G; Nicoletti G; Nisticò R; Salsone M; Novellino F; Barbagallo G; Vaccaro MG; Sabatini U; Vescio V; Stanà C; Rocca F; Caracciolo M; Quattrone A
    Parkinsonism Relat Disord; 2019 Jun; 63():124-130. PubMed ID: 30803901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.